FI913560A0 - Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin. - Google Patents
Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin.Info
- Publication number
- FI913560A0 FI913560A0 FI913560A FI913560A FI913560A0 FI 913560 A0 FI913560 A0 FI 913560A0 FI 913560 A FI913560 A FI 913560A FI 913560 A FI913560 A FI 913560A FI 913560 A0 FI913560 A0 FI 913560A0
- Authority
- FI
- Finland
- Prior art keywords
- hcv
- infektionsdiagnos
- kroppar
- foerhindrande
- peptider
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 101710172711 Structural protein Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/558,799 US5106726A (en) | 1990-02-16 | 1990-07-26 | Synthetic peptides specific for the detection of antibodies to HCV |
US65173591A | 1991-02-07 | 1991-02-07 | |
US66727591A | 1991-03-11 | 1991-03-11 | |
US71981991A | 1991-06-24 | 1991-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI913560A0 true FI913560A0 (fi) | 1991-07-25 |
FI913560A FI913560A (fi) | 1992-01-27 |
Family
ID=27504803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI913560A FI913560A (fi) | 1990-07-26 | 1991-07-25 | Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0468527B1 (fi) |
JP (1) | JP2763215B2 (fi) |
KR (1) | KR930008092B1 (fi) |
AT (1) | ATE179184T1 (fi) |
CA (1) | CA2047792C (fi) |
DE (2) | DE69131149D1 (fi) |
ES (1) | ES2058049T1 (fi) |
FI (1) | FI913560A (fi) |
GR (1) | GR940300008T1 (fi) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US5683864A (en) * | 1987-11-18 | 1997-11-04 | Chiron Corporation | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
US5372928A (en) * | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
US5308750A (en) * | 1989-12-22 | 1994-05-03 | Abbott Laboratories | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
US5639594A (en) * | 1990-02-16 | 1997-06-17 | United Biomedical, Inc. | Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
US5582968A (en) * | 1990-02-16 | 1996-12-10 | United Biomedical, Inc. | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis |
US5712087A (en) * | 1990-04-04 | 1998-01-27 | Chiron Corporation | Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens |
CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
DE59109271D1 (de) * | 1990-11-03 | 2006-04-27 | Dade Behring Marburg Gmbh | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung |
KR920703640A (ko) * | 1990-11-29 | 1992-12-18 | 테루카츄 아리마 | 비a비b형 간염 바이러스 항원 단백질 |
US5910404A (en) | 1990-12-14 | 1999-06-08 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
DK0644202T3 (da) * | 1990-12-14 | 1997-09-15 | Innogenetics Nv | Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus |
US6007982A (en) * | 1990-12-14 | 1999-12-28 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
CA2082924A1 (en) * | 1991-03-26 | 1992-09-27 | David C. Leahy | Assay for non-a non-b hepatitis |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
ES2188583T3 (es) | 1991-06-24 | 2003-07-01 | Chiron Corp | Polipeptidos para el virus de la hepatitis c (hcv). |
DE4209215A1 (de) * | 1991-07-04 | 1993-01-07 | Boehringer Mannheim Gmbh | Hcv peptidantigene und verfahren zur bestimmung von hcv |
CA2112667C (en) * | 1991-08-21 | 2004-02-17 | Smriti U. Mehta | Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
ZA927243B (en) * | 1991-10-07 | 1994-01-26 | Akzo Nv | Non-A, Non-B peptides |
WO1993010239A2 (en) | 1991-11-21 | 1993-05-27 | Common Services Agency | Hepatitis-c virus testing |
GB9203803D0 (en) * | 1992-02-21 | 1992-04-08 | Wellcome Found | A recombinant polypeptide |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
SG77551A1 (en) * | 1992-03-06 | 2005-04-28 | Innogenetics Nv | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
US5980899A (en) * | 1992-06-10 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells |
DE4240980A1 (de) * | 1992-08-07 | 1994-02-10 | Boehringer Mannheim Gmbh | HCV Peptidantigene und Verfahren zur Bestimmung von HCV |
IT1270941B (it) * | 1993-05-12 | 1997-05-26 | Sorin Biomedica Spa | Peptidi di hcv e loro usi. |
ATE249838T1 (de) | 1993-05-12 | 2003-10-15 | Chiron Corp | Konserviertes motiv der hepatitis c virus e2/ns1 region |
US5514539A (en) * | 1993-06-29 | 1996-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
WO1995011918A1 (fr) * | 1993-10-29 | 1995-05-04 | Srl, Inc. | Compose peptidique antigenique et methode de dosage immunologique |
DK0992580T3 (da) * | 1993-11-04 | 2005-07-11 | Innogenetics Nv | Epitoper på human T-celler, som er immundominante for hepatitis C-virus |
GB2294690B (en) * | 1994-11-01 | 1998-10-28 | United Biomedical Inc | Peptides effective for diagnosis and detection of hepatitis C infection |
US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
DE19540105C1 (de) * | 1995-09-19 | 1997-02-20 | United Biomedical Inc | Peptidzusammensetzungen zur Diagnose und zum Nachweis von Hepatitis C Virus (HCV)-Infektion |
JP3715027B2 (ja) * | 1996-05-07 | 2005-11-09 | シスメックス株式会社 | C型肝炎ウイルス感染症診断薬 |
AU752131C (en) * | 1997-11-06 | 2003-12-04 | Innogenetics N.V. | Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes |
KR20020028152A (ko) * | 2000-10-07 | 2002-04-16 | 박선옥 | 건강매트 |
DE10112748A1 (de) * | 2001-03-14 | 2002-09-19 | Transmit Technologietransfer | Erfindung betreffend HCV-Erkrankungen |
WO2002085932A2 (en) | 2001-04-24 | 2002-10-31 | Innogenetics N.V. | Constructs and methods for expression of recombinant hcv envelope proteins |
FR2839722A1 (fr) | 2002-05-17 | 2003-11-21 | Bio Merieux | Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c |
US20070073039A1 (en) * | 2005-09-29 | 2007-03-29 | Chisari Francis V | Peptides that inhibit viral infections |
EP3071217A2 (en) * | 2013-11-18 | 2016-09-28 | Westfälische Wilhelms-Universität Münster | Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02500880A (ja) * | 1987-11-18 | 1990-03-29 | カイロン コーポレイション | Nanbvの診断用薬およびワクチン |
JP2656995B2 (ja) * | 1989-03-17 | 1997-09-24 | カイロン コーポレイション | Nanbvの診断用薬 |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
-
1991
- 1991-07-24 CA CA002047792A patent/CA2047792C/en not_active Expired - Fee Related
- 1991-07-25 FI FI913560A patent/FI913560A/fi unknown
- 1991-07-26 DE DE69131149T patent/DE69131149D1/de not_active Expired - Lifetime
- 1991-07-26 JP JP3276101A patent/JP2763215B2/ja not_active Expired - Lifetime
- 1991-07-26 AT AT91112620T patent/ATE179184T1/de not_active IP Right Cessation
- 1991-07-26 DE DE91112620T patent/DE468527T1/de active Pending
- 1991-07-26 ES ES91112620T patent/ES2058049T1/es active Pending
- 1991-07-26 EP EP91112620A patent/EP0468527B1/en not_active Expired - Lifetime
- 1991-07-27 KR KR1019910012947A patent/KR930008092B1/ko not_active IP Right Cessation
-
1994
- 1994-02-28 GR GR940300008T patent/GR940300008T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU646275B2 (en) | 1994-02-17 |
FI913560A (fi) | 1992-01-27 |
ES2058049T1 (es) | 1994-11-01 |
JP2763215B2 (ja) | 1998-06-11 |
ATE179184T1 (de) | 1999-05-15 |
CA2047792C (en) | 2002-07-02 |
EP0468527A2 (en) | 1992-01-29 |
KR920002630A (ko) | 1992-02-28 |
KR930008092B1 (ko) | 1993-08-25 |
AU8139091A (en) | 1992-01-30 |
EP0468527B1 (en) | 1999-04-21 |
GR940300008T1 (fi) | 1994-02-28 |
EP0468527A3 (en) | 1992-08-19 |
CA2047792A1 (en) | 1992-01-27 |
DE468527T1 (de) | 1994-02-24 |
JPH05222094A (ja) | 1993-08-31 |
DE69131149D1 (de) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI913560A0 (fi) | Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin. | |
NO870412L (no) | Peptider. | |
ES2091301T3 (es) | Inmunoensayo de ciclosporina. | |
FI910720A0 (fi) | Syntetiska peptider specifika foer detektering av hcv-antikroppar, diagnos av hcv-infektion och prevention av infektionen som vaccin. | |
DK0522030T3 (da) | Hepatitis B-vaccine | |
FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
DK296087A (da) | Peptidmateriale og fremgangsmaade til paavisning af antistoffer til htlv-iii | |
EP0445423A3 (en) | Hepatitis c assay | |
ES2139571T3 (es) | Ensayo de hepatitis c que utiliza antigenos recombinantes. | |
DE69230917T2 (de) | Verfahren zur detektion von hepatitis c | |
JPS6470498A (en) | Synthetic peptide and antibody thereto | |
ES2052370T3 (es) | Peptidos o polipeptidos inmunologicamente activos del parvovirus b19. | |
ATE189683T1 (de) | Hcv peptidantigene und verfahren zur bestimmung von hcv |